Clinical trial
DiaGone™ First in Human (FIH) Study - Safety and Performance of the DiaGone™ Device for the Treatment of Type 2 Diabetes
NCT03390322 is registered in ClinicalTrials.gov with Digma Medical Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DiaGone™ First in Human (FIH) Study - Safety and Performance of the DiaGone™ Device for the Treatment of Type 2 Diabetes
- Lead sponsor
- Digma Medical Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 28, 2017
- Completion date
- August 31, 2024
- Enrollment
- 31 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.